Objectives: The first case of Coronavirus disease-19 in the United States was confirmed by the Centers for Disease Control (CDC) in January 2020. The presence of COVID-19 and the subsequent spread of this disease led to stress, anxiety, grief, and worry. We aimed to study the rate of hospital admission for alcohol use disorder (AUD) before and during the COVID-19 pandemic in a tertiary community hospital in Michigan.Methods: Two subsets of hospital data were collected for comparison between hospitalized patients before and during the pandemic in a tertiary community hospital. Logistic regression was used to identify the odds ratio of AUD admission rates among all patients in 2020 compared with 2019 while controlling for covariates.Results: Our data showed a statistically significant increase in AUD patients in 2020 compared to 2019 (3.26% versus 2.50%, adjusted OR=1.44 with P=0.002). In addition, females had significantly lower chances of admission for AUD compared with males (OR=0.22 with P<0.001) and African Americans had significantly lower chances of admission for AUD compared to Whites (OR=0.44 with P <0.001). Divorced patients had a higher probability of admission for AUD compared to married patients (OR=2.62 with P<0.001).Conclusion: Our study found a significantly higher rate of AUD admissions in 2020 during the COVID-19 Pandemic compared to 2019. Gender, race, age, and marital status are significant risk factors related to AUD admissions.

No abstract

11027 Background: Low density CT (LDCT) screening reduces lung cancer specific and all-cause mortality in high risk populations. However, it remains underutilized. Screening discussions often start in primary care clinics of which nearly 30% are occupied by residents. Recognizing gaps in knowledge in early medical training may translate into a higher utilization of LDCT screening. Methods: To evaluate knowledge about lung cancer screening in Internal Medicine (IM) residents at 4 academic programs we distributed a survey to assess population at risk, mortality benefits, comparison between LDCT, colonoscopy and mammogram, and a knowledge self assessment. Results: 166 out of 360 (46%) IM residents at the 4 institutions participated, including 42% PGY-1, 30% PGY-2, and 28% PGY-3. Residents attained an average of 2.9 correct responses out of 7 (43.1%), without any statistically significant difference among programs. PGY-1 residents performed better than PGY-2 and PGY-3 (p=0.022). 36% correctly identified the appropriate population for screening. 90% correctly indicated that LDCT screening results in a cancer specific mortality reduction. 59% correctly indicated that LDCT results in all-cause mortality reduction. 7.7% answered that women stand to benefit the most from screening. 66% correctly answered that LDCT underperforms colonoscopy regarding mortality reduction. 22% answered correctly that LDCT outperforms mammography in reducing mortality. 65% of residents perceived their knowledge to be average or lower. Conclusions: LDCT knowledge is deficient among the residents studied. PGY-1 residents performed significantly better than their upper level peers. There were no significant differences among institutions. [Table: see text]

No abstract

Introduction Lung cancer remains the leading cause of cancer-related death in the United States. Low density CT (LDCT) has been shown to reduce mortality in high-risk populations. Recognizing and mitigating gaps in knowledge in early medical training could result in increased utilization of screening CT in high risk-populations. Methods An electronic survey was conducted among Internal Medicine (IM) residents at 4 academic programs in the Midwestern United States. A survey was distributed to evaluate knowledge about high-risk populations, mortality benefits, and a comparison in mortality benefits between LDCT and other screening modalities using number needed to screen (NNS). Results: There was a 46.6% (166/360) response rate. Residents correctly answered an average of 2.9/7 (43.1%) questions. PGY-1 (post-graduate year) and PGY-2 residents performed better than PGY-3 (P = .022). Only 1/3 rd of all respondents correctly identified the population needed to be screened. Over 80% of residents thought screening with LDCT had a cancer-specific mortality benefit but were evenly split (except Program 2 residents), on recognizing an all-cause mortality benefit with LDCT, (P = .016). Only 7.7% thought women benefited the most from LDCT. Self-assess and attained knowledge were similar among programs. Conclusions LDCT is a noninvasive intervention with a substantial mortality reduction, especially in states with high rates of smoking, and is widely covered by insurers. With average knowledge score less than 50%, this study shows there is a substantial need to increase the knowledge of LCS in IM residency programs.